chemotaxin inhibitor (CV Therapeutics)

N/A

Report date: 2025/03/14 20:00:48
NME

Base Information

Drug Namechemotaxin inhibitor (CV Therapeutics)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMacrophage migration inhibitory factor modulators
TargetsMacrophage migration inhibitory factor
Therapy Area/IndicationsAtherosclerosisMyocardial Infarction
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGilead Palo Alto Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGilead Palo Alto IncBayer AG
Active IndicationsN/A
Inactive IndicationsAtherosclerosisMyocardial Infarction

Other Information

ATC CodeN/A
Related LinksN/A